- Home
- Companies
- usa oregon
- human disease
Refine by
Human Disease Suppliers Serving Usa Oregon
81 companies found
based inNY, NEW YORK (USA)
As a global Contract Research Organization (CRO), headquartered in New York, USA, Alfa Chemistry has served the pharmaceutical and biotechnology industries for years. Today, Alfa Chemistry is specialized in organic chemistry, material chemistry, and ...
Azaindoles and their derivatives exhibit significant biological activities, hence they are widely concerned in terms of drug optimization strategies. The four azaindole positional isomers, which associate a pyridine and a pyrrole ring by a fused C-C ...
based inBuenos Aires, ARGENTINA
Biocientifica S.A. was founded with the objective of manufacturing reagents for the diagnosis of human diseases by laboratory methods in Argentina. We are an innovative biotechnology company, being a reference in immunology and molecular biology. We ...
based inNew York City, NEW YORK (USA)
At Kallyope, we are pioneering the science and understanding of gut and gut-brain biology to create medicines that transform human health. Based in New York City, we are home to some of the world’s most intrepid scientific minds from the world’s top ...
At Kallyope, we are pioneering the science and understanding of gut and gut-brain biology to create medicines that transform human ...
based inMountain View, CALIFORNIA (USA)
Osel’s mission is to develop and commercialize a broad portfolio of Live Biotherapeutic Products (LBPs) that prevent or treat abnormal conditions resulting from a disruption of the human microbiome. In 2003, Osel was one of the first companies to ...
based inDiepenbeek, BELGIUM
Founded in 2012, InnoSer is an innovative and dynamic contract research organization supporting preclinical development of drugs from its facilities in Belgium and the Netherlands. InnoSer supports its customers in the critical steps of their drug ...
We have specialized facilities for in vitro and in vivo offerings. Our established scientific experience and customized, collaborative approach make InnoSer the ideal ally for your company to achieve meaningful, high-quality and fast results. ...
based inBoston, MASSACHUSETTS (USA)
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — ...
Vertex is focused on discovering, developing and commercializing innovative medicines so people with serious diseases can lead better lives. Our scientists don’t see the impossible as an obstacle; they see it as a good place to start. These ...
based inCharlottesville, VIRGINIA (USA)
HemoShear Therapeutics is a clinical stage company developing novel treatments for patients with rare diseases. We are implementing a new vision for how advanced biological and computational models can accelerate the discovery of innovative ...
HST5040 is an investigational small molecule therapy being developed by HemoShear to reduce the levels of toxins associated with methylmalonic acidemia (MMA) and propionic acidemia (PA), rare genetic disorders caused by the de?ciency of certain ...
based inJesi (AN), ITALY
Diatech Pharmacogenetics is the Italian leader in the development, production and commercialisation of pharmacogenetics tests for cancer precision medicine. Founded in 1996, Diatech Pharmacogenetics has sustained constant organic growth over the ...
based inMadison, WISCONSIN (USA)
Stem Pharm offers unique biomaterials for cell and tissue manufacturing. Applications include stem cell derived in vitro models for drug discovery and matrices for cell therapy and regenerative medicine. Stem Pharm was founded in 2015 with the ...
based inBentley DC, AUSTRALIA
Ozgene is one of the leading companies providing genetically modified mice for researchers around the world. We offer a full spectrum of pre-clinical capabilities from the development of mouse models through to breeding, characterisation and ...
These mouse models allow researchers to gain insight into how the loss of the gene affects physiology, behavior and disease development. Observing the characteristics of a knockout phenotype can also help researchers understand ...
based inMoscow, RUSSIA
3D Bioprinting Solutions is a Laboratory for Biotechnological Research founded by INVITRO, the largest private medical company in Russia. The laboratory develops and produces bioprinters and materials for 3D bioprinting, and also develops innov ...
FABION is the first Russian-made 3D bioprinter of original design and make for printing live and functional tissue and/or organ constructs, allowing precise layer-by-layer deployment of tissue spheroids (bioink) in hydrogel (biopaper) according to a ...
based inDurham, NORTH CAROLINA (USA)
Symberix, an early-stage spin-out of the University of North Carolina at Chapel Hill, aims to improve human health by pioneering the development of symbiotic drugs that work by controlling bacteria without killing them. Symberix’s scientific ...
based inNewton, MASSACHUSETTS (USA)
We are developing the next generation of bio-therapeutics for the treatment of autoimmunity and cancer. Recent breakthroughs in the field of immunology and immuno-oncology have opened the way for a new wave of transformative treatments. Despite ...
based inSan Francisco, CALIFORNIA (USA)
Tempo Bioscience, Inc (Tempo) develops human stem cells (human iPSC technology) based cell models and biosensor enabling technologies for preclinical drug discovery & development, biobanking, in vitro diagnostics, and biomarker development. Our ...
based inMons, BELGIUM
D-tek s.a. is a private Belgian biotechnology company created in 1995 in Mons (40 km from Brussels and less than 1h20 from Paris). The company is located in 1.200 square meters facilities in the Scientific Park Initialis of Mons. The company is ...
based inBaltimore, MARYLAND (USA)
Aidar Health is a healthcare technology and digital therapeutics company reimagining today’s standards for clinical trials, chronic care management, and health monitoring. Our rapid medical assessment device, MouthLab, is a non-invasive, hand-held, ...
MouthLab Mobile Monitoring System makes precision medicine a reality by rapidly gathering, and efficiently analyzing a large amount of clinically relevant subjective and objective information in real-time. It's as simple to use as a toothbrush yet ...
based inWoburn, MASSACHUSETTS (USA)
We are an investigational-stage infectious disease company focused on combating all diseases resulting from herpes simplex virus 1 (HSV-1) and herpes simplex virus 2 (HSV-2) infections. Using our proprietary technology, we are developing rationally ...
One of the most celebrated achievements of modern medicine is the eradication of the smallpox virus with the use of a live-attenuated vaccine. We are advancing the applied science of attenuating live viruses to develop an entirely new class of ...
based inResearch Triangle Park, NORTH CAROLINA (USA)
Galaxy Diagnostics was launched in 2009 to commercialize a more sensitive test method for Bartonella species infection, called Bartonella ePCR. The underlying technology, developed by Galaxy cofounders, Drs. Ed Breitschwerdt and Ricardo Maggi at NC ...
Test methods, such as immunofluorescence assays (IFA), determine the level of IgM and/or IgG antibodies circulating in a patient, which can be useful for diagnosis of bartonellosis and monitoring treatment response. Almost 20 Bartonella species have ...
based inSchlieren, SWITZERLAND
InSphero sets the standard for in vitro testing of novel drugs in the pharmaceutical and biotechnology industry with comprehensive solutions that provide greater confidence in decision making. Our robust and highly physiologically relevant suite of ...
Test efficacy of anti-NASH drugs in an advanced 3D human liver disease model. The InSphero 3D InSight™ Human Liver NASH Model consists of an advanced microtissue co-culture of healthy primary ...
based inSeattle, WASHINGTON (USA)
We believe we are entering a new era of medicine. The ability to modify genes and use cells as medicines provides new tools to meaningfully change the outcome of many human diseases. Early pioneers have made good progress, but most of what we can ...